Patents by Inventor Shuiping Zhou

Shuiping Zhou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230334009
    Abstract: A data archiving method includes: finding, in local space when an archiving task for a target block header exists, current state trees of block headers, the current state trees including a current state tree that the target block header points to and a current state tree that a first block header before the target block header points to; reconstructing new state trees according to the found current state trees, node reuse information between the current state trees, and target state data corresponding to a second block header after the target block header; and archiving the current state trees stored in the local space to a target archiving server, and deleting the current state trees in the local space after successful archiving.
    Type: Application
    Filed: June 22, 2023
    Publication date: October 19, 2023
    Inventors: Haoming FENG, Haitao TU, Libao HE, Qiuping CHEN, Jiabao CHEN, Peng REN, Shuiping ZHOU, Yong ZHAO, He WANG
  • Publication number: 20230090296
    Abstract: A transaction transmitted by a user node in a blockchain network and transaction verification information corresponding to the to-be-verified transaction are acquired. The transaction verification information includes a state read set, a state write set, an initial transaction execution result, and a block identifier of a target block. A first block header of the target block includes the block identifier. A second block header is determined from a block header chain of a light node in the blockchain network. The state read set and the state write set are checked based on a first state snapshot in the second block header. The transaction service is executed to obtain a target transaction execution result corresponding to the transaction service and to-be-written state data. Legitimacy of the to-be-verified transaction is checked based on the initial transaction execution result, the target transaction execution result, the state write set, and the to-be-written state data.
    Type: Application
    Filed: November 30, 2022
    Publication date: March 23, 2023
    Applicant: Tencent Technology (Shenzhen) Company Limited
    Inventors: Haoming FENG, Haitao TU, Libao HE, Qiuping CHEN, Jiabao CHEN, Peng REN, Shuiping ZHOU, Yong ZHAO, He WANG
  • Publication number: 20220395539
    Abstract: A traditional Chinese medicine composition for treating psoriasis, a preparation method therefor and a use thereof. The traditional Chinese medicine composition comprises: water buffalo horn powder, Japanese honeysuckle flower, gypsum, red peony root, peony bark, charred cape jasmine fruit, baical skullcap root, raw garden burnet root, and liquorice root. The preparation method comprises: proportionally weighing out the baical skullcap root, the Japanese honeysuckle flower, the red peony root, the peony bark, the gypsum, the charred cape jasmine fruit, the garden burnet root and the liquorice root, adding water and decocting 1 to 3 times, each time using 4 to 10 times the amount (weight to volume ratio) of water and decocting for 0.5 to 3 hours; combining decoctions, filtering, vacuum concentrating the filtrate, drying same, adding the water buffalo horn powder and mixing until evenly distributed.
    Type: Application
    Filed: November 10, 2020
    Publication date: December 15, 2022
    Inventors: Yi HE, Shuiping ZHOU, Yu WANG, Yuanpeng JIN, Jinghua KANG, Zhipeng HUO, Zhijuan HUANG, Yuanxue LIU, Zhaohui SONG
  • Patent number: 11491173
    Abstract: Disclosed are a pharmaceutical composition and an application thereof. The pharmaceutical composition of the present invention comprises the following components in parts by weight: 2-20 parts of phenolic acids, 0.5-5 parts of flavonoids, 0.005-0.5 part of tanshinones, 5-20 parts of saponins, and 10-18 parts of volatile oils. The pharmaceutical composition has the functions of protecting against myocardial damage and treating heart failure.
    Type: Grant
    Filed: April 4, 2019
    Date of Patent: November 8, 2022
    Assignee: TASLY PHARMACEUTICAL GROUP CO., LTD.
    Inventors: Shuiping Zhou, He Sun, Yiqian Zhang, Xiaohui Ma, Jiawen Shi, Yi He, Xinxin Li, Jing Wang, Xiaoqing Li, Lijun Fan, Jingjing Zhang
  • Publication number: 20210038668
    Abstract: The present invention discloses a traditional Chinese medicinal composition for preventing and/or treating ischemia reperfusion injury; the traditional Chinese medicinal composition consists of salvianolic acids, Panax notoginseng saponins and total saponins of Astragalus.
    Type: Application
    Filed: March 25, 2019
    Publication date: February 11, 2021
    Inventors: Jingyan HAN, Qingfang CHEN, Dandan HUANG, Xiaohui MA, Yi HE, Shuiping ZHOU
  • Patent number: 10874636
    Abstract: Disclosed is an application of substituted cinnamamide derivatives in the preparation of anti-anxiety medications, the substituted cinnammide derivatives are compounds having the structure of formula (I) or pharmaceutically acceptable salts thereof, wherein, R1 is —H, —OH, —F, —Cl, —Br, —I, —OCH3, —OCF3, —OCHF2, —OCH2F, —CF3, —CHF2, —CH2F, —CH3, —CH3CH2, —CF3CH2, —CN, —NO2, —NH2 or —COOR5; R2 is H, C1-C10 linear alkyl, C3-C10 branched alkyl, C3-C10 cyclic alkyl, C1-C10 hydroxyalkyl or a N-substituted piperazine-derived group; or R2 is a group forming with adjacent Y a tetrahydropyrrolyl group, a piperidyl group or a cyclohexanimido group.
    Type: Grant
    Filed: January 20, 2017
    Date of Patent: December 29, 2020
    Assignee: Tasly Pharmaceutical Group Co., Ltd.
    Inventors: Min Han, Xiaohui Ma, Wangyi Zhou, Yanyong Liu, Yanchuan Li, Jing Wang, Shuiping Zhou, He Sun, Yonghong Zhu
  • Patent number: 10626077
    Abstract: The present invention relates to the medical field, specifically a salvianolic acid T as described in structural formula (I), a chiral isomer thereof, a preparation method therefor, pharmaceutical compositions, antioxidants, and free radical scavengers thereof, and a use of the compound.
    Type: Grant
    Filed: August 26, 2014
    Date of Patent: April 21, 2020
    Assignee: Tasly Pharmaceutical Group Co., LTD.
    Inventors: Shuiping Zhou, Wei Li, Yuanpeng Jin, Xinxin Li, Xiaohui Ma, Wei Zhou, Min Han, Shuming Li
  • Patent number: 10314923
    Abstract: A silybin injection contains silybin, sulfobutyl ether-?-cyclodextrin, an organic solvent for injection, a pH regulator, and may further contain a co-solvent, a lyophilization bulking agent, and water for injection.
    Type: Grant
    Filed: December 24, 2015
    Date of Patent: June 11, 2019
    Assignee: Tasly Pharmaceutical Group Co., Ltd.
    Inventors: Jianming Chen, Baoan Gao, Qinqin Zhou, Shuiping Zhou, Nan Cai, Yuansheng Zhang, Chan Wu, Nong Yu, Lina Chen, Wenli Liu
  • Publication number: 20190046500
    Abstract: Disclosed is an application of substituted cinnamamide derivatives in the preparation of anti-anxiety medications, the substituted cinnammide derivatives are compounds having the structure of formula (I) or pharmaceutically acceptable salts thereof, wherein, R1 is —H, —OH, —F, —Cl, —Br, —I, —OCH3, —OCF3, —OCHF2, —OCH2F, —CF3, —CHF2, —CH2F, —CH3, —CH3CH2, —CF3CH2, —CN, —NO2, —NH2 or —COOR5; R2 is H, C1-C10 linear alkyl, C3-C10 branched alkyl, C3-C10 cyclic alkyl, C1-C10 hydroxyalkyl or a N-substituted piperazine-derived group; or R2 is a group forming with adjacent Y a tetrahydropyrrolyl group, a piperidyl group or a cyclohexanimido group.
    Type: Application
    Filed: January 20, 2017
    Publication date: February 14, 2019
    Inventors: Min HAN, Xiaohui MA, Wangyi ZHOU, Yanyong LIU, Yanchuan LI, Jing WANG, Shuiping ZHOU, He SUN, Yonghong ZHU
  • Patent number: 10071989
    Abstract: The present invention relates to substituted cinnamamide derivatives, the method for preparing thereof and the use thereof. Each of said derivatives has a structure of formula (I). The method for preparing the substituted cinnamamides and their derivatives of the present invention is also disclosed. Substituted piperonal derivatives are selected as starting materials to prepare the substituted cinnamamide derivatives of the present invention by Wittig reaction and acid-amine condensation reaction. Further, a use of the present compounds in preventing and treating depressive-type mental diseases is disclosed.
    Type: Grant
    Filed: June 26, 2012
    Date of Patent: September 11, 2018
    Assignee: TASLY PHARMACEUTICAL GROUP CO., LTD.
    Inventors: Xiaohui Ma, Yuanpeng Jin, Min Han, Shuiping Zhou, Wangyi Zhou, Xuejun Luo, Guocheng Wang, Lulu Yan, Lanlan Zhang, Yonghong Zhu
  • Patent number: 9889093
    Abstract: The present invention relates to an andrographolide enteric targeting micropellet and a method for preparation thereof; furthermore, the present invention also relates to uses of andrographolide and andrographolide enteric targeting micropellets in preparation of a pharmaceutical for treatment of inflammatory bowel disease.
    Type: Grant
    Filed: August 6, 2014
    Date of Patent: February 13, 2018
    Assignee: Tasly Pharmaceutical Group Co., Ltd.
    Inventors: Henry Sun, Xiaohui Ma, Zhixin Guo, Sen Lin, Genbei Wang, Lulu Yan, Lihua Zhang, Shuiping Zhou, Shunnan Zhang
  • Publication number: 20180000965
    Abstract: A silybin injection contains silybin, sulfobutyl ether-?-cyclodextrin, an organic solvent for injection and may further contain a co-solvent, a lyophilization proppant, a pH regulator, water for injection and the like.
    Type: Application
    Filed: December 24, 2015
    Publication date: January 4, 2018
    Inventors: Jianming CHEN, Baoan GAO, Qinqin ZHOU, Shuiping ZHOU, Nan CAI, Yuansheng ZHANG, Chan WU, Nong YU, Lina CHEN, Wenli LIU
  • Publication number: 20170224623
    Abstract: The present invention relates to an andrographolide enteric targeting micropellet and method for preparation thereof; furthermore, the present invention also relates to uses of andrographolide and andrographolide enteric targeting micropellets in the preparation of a pharmaceutical for treatment of inflammatory bowel disease.
    Type: Application
    Filed: March 27, 2017
    Publication date: August 10, 2017
    Inventors: Henry Sun, Xiaohui Ma, Zhixin Guo, Sen Lin, Genbei Wang, Lulu Yan, Lihua Zhang, Shuiping Zhou, Shunnan Zhang
  • Publication number: 20170224622
    Abstract: The present invention relates to an andrographolide enteric targeting micropellet and method for preparation thereof; furthermore, the present invention also relates to uses of andrographolide and andrographolide enteric targeting micropellets in the preparation of a pharmaceutical for treatment of inflammatory bowel disease.
    Type: Application
    Filed: March 27, 2017
    Publication date: August 10, 2017
    Inventors: Henry Sun, Xiaohui Ma, Zhixin Guo, Sen Lin, Genbei Wang, Lulu Yan, Lihua Zhang, Shuiping Zhou, Shunnan Zhang
  • Publication number: 20160200661
    Abstract: The present invention relates to the medical field, specifically a salvianolic acid T as described in structural formula (I), a chiral isomer thereof, a preparation method therefor, pharmaceutical compositions, antioxidants, and free radical scavengers thereof, and a use of the compound.
    Type: Application
    Filed: August 26, 2014
    Publication date: July 14, 2016
    Inventors: Shuiping Zhou, Wei Li, Yuanpeng Jin, Xinxin Li, Xiaohui Ma, Wei Zhou, Min Han, Shuming Li
  • Publication number: 20160175253
    Abstract: The present invention relates to an andrographolide enteric targeting micropellet and a method for preparation thereof; furthermore, the present invention also relates to uses of andrographolide and andrographolide enteric targeting micropellets in preparation of a pharmaceutical for treatment of inflammatory bowel disease.
    Type: Application
    Filed: August 6, 2014
    Publication date: June 23, 2016
    Inventors: Henry Sun, Xiaohui Ma, Zhixin Guo, Sen Lin, Genbei Wang, Lulu Yan, Lihua Zhang, Shuiping Zhou, Shunnan Zhang
  • Patent number: 9205123
    Abstract: A capsule of compound danshen dripping pills are disclosed. The color of the capsule's shell is orange, yellow, green or blue and all of these colors are in the wavelength range of 446-620 nm.
    Type: Grant
    Filed: February 17, 2011
    Date of Patent: December 8, 2015
    Assignee: Tasly Pharmaceutical Group Co., Ltd.
    Inventors: He Sun, Shuiping Zhou, Lanlan Zhang, Zhijuan Huang, Zhaohui Song
  • Publication number: 20140121242
    Abstract: The present invention relates to substituted cinnamamide derivatives, the method for preparing thereof and the use thereof. Each of said derivatives has a structure of formula (I). The method for preparing the substituted cinnamamides and their derivatives of the present invention is also disclosed. Substituted piperonal derivatives are selected as starting materials to prepare the substituted cinnamamide derivatives of the present invention by Wittig reaction and acid-amine condensation reaction. Further, a use of the present compounds in preventing and treating depressive-type mental diseases is disclosed.
    Type: Application
    Filed: June 26, 2012
    Publication date: May 1, 2014
    Applicant: TASLY PHARMACEUTICAL GROUP CO., LTD.
    Inventors: Xiaohui Ma, Yuanpeng Jin, Min Han, Shuiping Zhou, Wangyi Zhou, Xuejun Luo, Guocheng Wang, Lulu Yan, Lanlan Zhang, Yonghong Zhu
  • Patent number: 8637092
    Abstract: The present invention relates to methods for preparing a pharmaceutical composition for treating diabetes mellitus and the pharmaceutical composition prepared by the methods. The pharmaceutical composition of the present invention comprises extracts of the following crude drugs: 5-40 weight parts of Radix Trichosanthis (Tianhuafen), 10-30 weight parts of Radix Bupleuri (Chaihu), 3-15 weight parts of Fructus Aurantii Immaturus (Zhishi), 1-6 weight parts of Radix et Rhizoma Rhei (Dahuang), 1-12 weight parts of Rhizoma Pinelliae (Banxia), 3-15 weight parts of Radix Scutellariae (Huangqin), 1-12 weight parts of Rhizoma Coptidis (Huanglian), 3-15 weight parts of Radix Paeoniae Alba (Baishao) and 5-20 weight parts of Fructus Mume (Wumei), and optionally comprises pharmaceutically acceptable excipient. Also, the pharmaceutical composition of the present invention can further comprise Fructus Crataegi (Shanzha). Additionally, the present invention discloses four methods for preparing the pharmaceutical composition.
    Type: Grant
    Filed: July 28, 2008
    Date of Patent: January 28, 2014
    Assignee: Tasly Pharmaceutical Group Co., Ltd.
    Inventors: Xiaolin Tong, Yonghong Zhu, Shuiping Zhou, Xiuhui E, Shuangming Wang, Zhongting Xia
  • Publication number: 20120315328
    Abstract: A capsule of compound danshen dripping pills are disclosed. The color of the capsule's shell is orange, yellow, green or blue and all of these colors are in the wavelength range of 446-620 nm.
    Type: Application
    Filed: February 17, 2011
    Publication date: December 13, 2012
    Applicant: Tasly Pharmaceutical Group Co., Ltd.
    Inventors: He Sun, Shuiping Zhou, Lanlan Zhang, Zhijuan Huang, Zhaohui Song